#ZETA Zeta Global 2024 Q3 [EPS Miss by 29%]: - Revenue: $268.3 million - Adj. EPS: -$0.09 vs. forecast -$0.07 (5 analysts) - Share Price Impact: -37% - 4Q24 Revenue Guidance: 40% Y/Y growth "The bets we made seven years..." Watch our analysis: youtube.com/watch?v=seHV8K…

#VNRX VolitionRx 2024 Q3: - Revenue Q3 2024: $475,000 - Revenue Growth Q3: 187% YOY - YTD Revenue: $1 million, up 96% - Cash Used in Q3: $5.4 million, down 36% YOY - Nu.Q® Vet Tests Sold: 110,000 - Cash Equivalents: $5.4..." Watch our analysis: youtube.com/watch?v=mDJQi9…

#AREC American Resources 2024 Q3: - Revenue: $235,443 - Adj. EPS: -$0.13 vs. forecast -$0.10 (1 analyst) - Net Loss: $9.8 million - Strategic Partnerships: IRIS Metals and Vulcan Elements Mark Jensen, Chairman and CEO, ..." Watch our analysis: youtube.com/watch?v=PIRTPU…

#SRTS Sensus Healthcare 2024 Q3: - Revenue: $8.8 million - Adj. EPS: $0.07 vs. forecast -$0.01 (2 analysts) - Net Income: $1.2 million - Fair Deal Agreements: 22 signed - Cash Position: $22.6 million "Continued growth i..." Watch our analysis: youtube.com/watch?v=QWBkla…

#GCTS GCT Semiconductor Holding 2024 Q3: - Net Revenue: $2.6 million - Gross Margin: 62.3% - Net Loss: $7.1 million - Adj. EPS: -0.16 vs. forecast -0.16 (1 analyst) - 5G Chipset Shipments: 1H 2025 "We are excited about ..." Watch our analysis: youtube.com/watch?v=WNmn9A…

#INO INOVIO 2024 Q3 [EPS Beat by 26%]: - Net Loss Q3 2024: $25.2M - EPS Q3 2024: -$0.89 vs. Forecast -$1.20 (3 analysts) - Cash Runway: Extends into Q3 2025 - INO-3107 BLA Submission: Mid-2025 "We continue to be focused..." Watch our analysis: youtube.com/watch?v=1XaXkX…

#AKYA Akoya Biosciences 2024 Q3 [EPS Miss by 11%]: - Revenue: $18.8 million - Gross Margin: 62.3% - Operating Expenses: $20.1 million - Loss from Operations: $8.3 million - 2024 Revenue Forecast: $80M-$85M "Our third-qu..." Watch our analysis: youtube.com/watch?v=fRhuJQ…

#LCTX Lineage Cell Therapeutics 2024 Q3: - Revenue: $3.8 million - Adj. EPS: -$0.02 vs. forecast -$0.04 (3 analysts) - Cash Reserves: $32.7 million - OpRegen RMAT Designation "We were delighted to see our partners’ cont..." Watch our analysis: youtube.com/watch?v=ORjpOE…

#NGS Natural Gas Services Group 2024 Q3 [EPS Beat by 9%]: - Revenue: $20 million - Adj EPS: $0.25 vs. forecast $0.23 (1 analyst) - Net Income: $3 million - Operational Cost Reduction: 10% Watch our analysis: youtube.com/watch?v=iAk7tw…

#HYLN Hyliion 2024 Q3 [EPS Beat by 14%]: - Revenue: $0 - Net Loss: $11.2M - Cash and Investments: $237.5M - KARNO Generator: Strong Demand - 2025 Revenue Guidance: Low Double-Digit Millions "Hyliion is pleased to report..." Watch our analysis: youtube.com/watch?v=OqXabM…

#CELC Celcuity 2024 Q3: - Operating Expenses: $30.1M - Net Loss: $29.8M - Adj. EPS: -$0.65 vs. forecast -$0.65 (5 analysts) - Cash Position: $264M - VIKTORIA-1 Enrollment: 100% for PIK3CA wild-type - VIKTORIA-2: First pa..." Watch our analysis: youtube.com/watch?v=mHt-l2…

#ESE ESCO 2024 Q4 & Full Year [EPS Beat by 2%]: - Q4 Sales: $299M, up 9.5% - FY 2024 Sales: $1.03B, up 7.4% - Q4 Adj EPS: $1.46, up 16.8% - FY 2024 Adj EPS: $4.18, up 13.0% - SM&P Acquisition: $550M "We finished the yea..." Watch our analysis: youtube.com/watch?v=U3rv8P…

#ASTS AST SpaceMobile 2024 Q3 [EPS Miss by 511%]: - Revenue: $1.1 million - Net Loss: $171.9 million - Cash Position: $518.9 million - BlueBird Satellites: 5 operational - Forecast EPS: -$0.18 vs. Actual EPS: -$1.10 (2 a..." Watch our analysis: youtube.com/watch?v=n2oylI…

#AMAT Applied Materials 2024 Q4 & Full Year [EPS Beat by 6%]: - Revenue: $7.05 billion - Adj. EPS: $2.32 vs. forecast $2.18 (11 analysts) - Cash from Operations: $2.58 billion - Shareholder Returns: $1.77 billion “Appli... Watch our analysis: youtube.com/watch?v=Ti5wZf…

#PLX Protalix BioTherapeutics 2024 Q3 [EPS Miss by 33%]: - Revenue: $17.8 million - Net Income: $3.2 million - EPS: $0.04 vs. forecast $0.06 (1 analyst) - Cash Position: $27.4 million - PRX-115 Phase I Completed "We are..." Watch our analysis: youtube.com/watch?v=yfCK0I…

#SOWG Sow Good 2024 Q3 [EPS Miss by 94%]: - Revenue Q3 2024: $3.6 million - Net Loss Q3 2024: $3.4 million - Cash Reserves: $6.9 million - Adjusted EBITDA Q3 2024: -$1.9 million - Forecast EPS: -$0.17 vs. Actual EPS: -$0..." Watch our analysis: youtube.com/watch?v=Eo96Gw…

#PDSB PDS Biotech 2024 Q3: - Net Loss Q3 2024: $10.7M - EPS Q3 2024: -$0.29 vs. forecast -$0.29 (3 analysts) - Operating Expenses Q3 2024: $10.2M - Cash Reserves: $49.8M - VERSATILE-003 Trial: Phase 3 Update "Since our ..." Watch our analysis: youtube.com/watch?v=nLXniE…

#IVVD Invivyd 2024 Q3 [EPS Miss by 59%]: - Revenue: $9.3 million - Adj. EPS: -0.51 vs. forecast -0.32 (2 analysts) - Cash Position: $106.9 million - Projected Year-End Cash: $65 million "With the current Fact Sheet that..." Watch our analysis: youtube.com/watch?v=dEYhEO…

#DTI Drilling Tools International 2024 Q3: - Revenue Q3 2024: $40.1M - Adj. EPS Q3 2024: $0.03 vs. forecast $0.06 (2 analysts) - Adj. Free Cash Flow FY 2024: $18M-$21M - M&A Strategy: 5 Near-term Targets Watch our analysis: youtube.com/watch?v=XA4vwI…

#TSHA Taysha Gene Therapies 2024 Q3 [EPS Miss by 25%]: - Revenue: $1.8M - Net Loss: $25.5M - EPS: -$0.10 vs. forecast -$0.08 (3 analysts) - Cash Reserves: $157.7M - FDA Alignment: Achieved for TSHA-102 trials "We are pl..." Watch our analysis: youtube.com/watch?v=aA6vwb…